Robert Clarke, Pamela A.G. Clarke, Anni Wärri, and Katherine L. Cook. Heterozygous ATG7 inhibition enhances endocrine therapy responsiveness through regulation of damage associated molecular patterns and priming the immune system in ER+ breast tumors. AACR; Cancer Res. 2016; 76(14 Suppl):Abstract nr 904.